Target intelligence / Profile preview

Blood stasis expulsion

Molecular classification
Other
01

Overview

Blood stasis expulsion (Huo-Xue-Hua-Yu) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) focused on promoting blood circulation and resolving clots or stagnation (Wang et al., 2018, PubMed). It is not a discrete molecular target, such as a protein or receptor, but rather a functional classification for drugs and treatments that address 'blood stasis syndrome,' a pathological state characterized by impaired blood flow and hypercoagulability (Li et al., 2020, PubMed). In modern biomedical terms, this concept corresponds to the modulation of hemorheological parameters, microcirculation, and the coagulation cascade (Chen et al., 2011, Journal of Ethnopharmacology). Drugs described as 'expelling blood stasis' typically exert their effects by targeting multiple pathways, including the inhibition of platelet activation (e.g., via TXA2 or ADP receptors) and the enhancement of fibrinolysis (NIH/NCCIH). This strategy is widely applied in the clinical management of cardiovascular and cerebrovascular diseases where ischemia and thrombosis are primary concerns. Because it describes a physiological process or a multi-factorial therapeutic effect rather than a single biological entity, it is considered an 'incorrect' entry for a specific molecular target (Poon et al., 2012, Clinical Phytoscience).

Other names
Huoxue HuayuActivating blood and removing stasisInvigorating blood circulationResolving blood stasisPromoting blood circulation and removing blood stasis
02

Mechanism of action

The pharmacological action involves the inhibition of platelet aggregation, reduction of blood viscosity, improvement of microvascular blood flow, and modulation of the coagulation-fibrinolysis system through multiple molecular pathways such as COX-1 inhibition or P2Y12 antagonism.

03

Biological functions

Blood circulationHemostasisFibrinolysisPlatelet aggregationMicrocirculation regulationVasodilation
04

Disease associations

Cardiovascular diseaseThrombosisStrokeInflammationIschemic heart diseaseAngina pectorisDysmenorrhea
05

Safety considerations

Increased risk of hemorrhageExcessive bleeding during surgeryDrug-herb interactions with anticoagulantsContraindicated in pregnancy due to risk of miscarriage
06

Interacting drugs

Aspirin

7 more in the full profile.

07

Biomarkers

D-dimerFibrinogen levelsPlatelet aggregation rateProthrombin time (PT)Activated partial thromboplastin time (aPTT)Plasma viscosity

Beyond the preview

Go deeper on Blood stasis expulsion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood stasis expulsion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call